Show simple item record

78P Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (D GC) in patients (pts) with advanced biliary tract cancer (BTC) (vol 33, pg s1462, 2022)

dc.contributor.authorOh, D.en
dc.contributor.authorHe, A. R.en
dc.contributor.authorQin, S.en
dc.contributor.authorChen, L.en
dc.contributor.authorOkusaka, T.en
dc.contributor.authorVogel, A.en
dc.contributor.authorKim, J. W.en
dc.contributor.authorSuksombooncharoen, T.en
dc.contributor.authorLee, M. A.en
dc.contributor.authorKitano, M.en
dc.contributor.authorBurris, H. A.en
dc.contributor.authorBouattour, M.en
dc.contributor.authorTanasa, S.en
dc.contributor.authorZaucha, R. E.en
dc.contributor.authorAvallone, A.en
dc.contributor.authorCundom, J. E.en
dc.contributor.authorRokutanda, N.en
dc.contributor.authorZotkiewicz, M.en
dc.contributor.authorCohen, G.en
dc.contributor.authorValle, Juan Wen
dc.date.accessioned2023-09-18T09:48:17Z
dc.date.available2023-09-18T09:48:17Z
dc.date.issued2023en
dc.identifier.citationOh D, He AR, Qin S, Chen L, Okusaka T, Vogel A, et al. 78P Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (D GC) in patients (pts) with advanced biliary tract cancer (BTC) (vol 33, pg s1462, 2022). Annals of Oncology. 2023 Jul;34(7):633-. PubMed PMID: WOS:001033922200001.en
dc.identifier.doi10.1016/annonc/annonc1123en
dc.identifier.urihttp://hdl.handle.net/10541/626531
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/annonc/annonc1123en
dc.title78P Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (D GC) in patients (pts) with advanced biliary tract cancer (BTC) (vol 33, pg s1462, 2022)en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentDivision Of Medical Oncology, Department Of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, 110-744 - Seoul/KRen
dc.identifier.journalAnnals of Oncologyen
dc.description.noteen]


Files in this item

This item appears in the following Collection(s)

Show simple item record